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Abstract
Background and Purpose—This randomized controlled trial tests the efficacy of bilateral arm
training with rhythmic auditory cueing (BATRAC) versus dose-matched therapeutic exercises
(DMTEs) on upper-extremity (UE) function in stroke survivors and uses functional magnetic
resonance imaging (fMRI) to examine effects on cortical reorganization.
Methods—A total of 111 adults with chronic UE paresis were randomized to 6 weeks (3×/week)
of BATRAC or DMTE. Primary end points of UE assessments of Fugl-Meyer UE Test (FM) and
modified Wolf Motor Function Test Time (WT) were performed 6 weeks prior to and at baseline,
after training, and 4 months later. Pretraining and posttraining, fMRI for UE movement was
evaluated in 17 BATRAC and 21 DMTE participants.
Results—The improvements in UE function (BATRAC: FM Δ = 1.1 + 0.5, P = .03; WT Δ =
−2.6 + 0.8, P < .00; DMTE: FM Δ = 1.9 + 0.4, P < .00; WT Δ = −1.6 + 0.7; P = .04) were
comparable between groups and retained after 4 months. Satisfaction was higher after BATRAC
than DMTE (P = .003). BATRAC led to significantly higher increase in activation in ipsilesional
precentral, anterior cingulate and postcentral gyri, and supplementary motor area and
contralesional superior frontal gyrus (P < .05). Activation change in the latter was correlated with
improvement in the WMFT (P = .01).
Conclusions—BATRAC is not superior to DMTE, but both rehabilitation programs durably
improve motor function for individuals with chronic UE hemiparesis and with varied deficit
severity. Adaptations in brain activation are greater after BATRAC than DMTE, suggesting that
given similar benefits to motor function, these therapies operate through different mechanisms.
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Introduction
Rehabilitation for stroke survivors with moderate to severe paresis after stroke remains a
challenge. Furthermore, there are few randomized controlled trials testing unilateral or
bilateral upper-extremity (UE) rehabilitation interventions.1–5 The largest recent trial
demonstrated that 2 weeks of constraint-induced movement therapy (CIMT) significantly
improves UE function more than usual care, persisting for at least 24 months.6,7 However,
CIMT requires the ability to partially extend the wrist and fingers, which limits the success
of CIMT in many stroke survivors. In contrast, bilateral arm training with rhythmic auditory
cueing (BATRAC) is targeted to rehabilitate stroke survivors with UE impairments that rule
out CIMT.
BATRAC, like CIMT, is based on motor learning principles, including repetition, feedback,
and goal setting with the aim of overcoming learned nonuse and relative inactivity,6,8–14 but
also includes use of the nonparetic arm as a fundamental component of the training based on
interlimb coupling theory, where the 2 arms act to form a “neurofunctional” unit.15–17
Evidence from nondisabled people suggest that bilateral arm movements engage additional
brain circuits, for example, in the supplementary motor area (SMA) and primary motor
cortex18–22 over and above the combination of similar unilateral arm movements. Thus,
training these circuits is useful for bilateral movements, and there also appears to be a
neurophysiological and functional transfer effect to unilateral movements after short-term
training in nondisabled people23 as well as in those with stroke.24 Plausible pathways that
are disinhibited or facilitated during bilateral as opposed to unilateral movements include
transcallosal,25 ipsilateral uncrossed corticospinal, and bilateral brainstem pathways such as
rubrospinal or propriospinal.26 Taken together, the neurophysiological and functional
evidence suggests a possible benefit from bilateral arm training to the paretic arm.
Uncontrolled studies with BATRAC27–29 have shown functional benefits, and 1 small
controlled study showed increased bihemispheric cortical activation associated with
improved UE function after BATRAC, suggesting cortical plasticity.30 The small sample,
heterogeneity of the functional and MRI responses, and no assessment of durability led to
this randomized controlled trial to test the hypotheses that BATRAC will result in larger and
more durable UE functional gains, mediated through remodeling of bihemispheric motor
and/or premotor cortical networks, compared with dose-matched unilateral therapeutic
exercises (DMTE controls).
Materials and Methods
Recruitment, screening, enrollment, and randomization of participants was conducted at the
Baltimore Veterans Affairs Medical Center (VAMC) and involved referrals from the
University of Maryland (UM) Medical System Hospital and regionwide advertisements
(Figure 1). Those included had a unilateral stroke >6 months earlier, could follow simple
instructions, had volitional control of the nonparetic arm, and the ability to flex the paretic
arm shoulder 3 inches from a neutral position. Exclusion criteria included symptomatic heart
disease, and uncontrolled hypertension (>180/100 mm Hg), significant orthopedic or chronic
pain conditions, untreated poststroke depression (Center for Epidemiological Studies
Depression Scale; cutoff > 16), active cancer, severe obstructive pulmonary disease, and
cognitive loss measured using the Folstein Mini Mental State Exam. In all, 54 participants
did not undertake the functional magnetic resonance imaging (fMRI): reasons included
metallic implants/pacemakers (16); claustrophobia (8); over a certain weight (7); not eligible
for transcranial magnetic stimulation, which was initially a cocriterion (5); and low
functioning (4). Fourteen participants were in an earlier report,30 so were excluded here. We
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kept these 14 participants in the functional data set because outcomes were not the emphasis
of the previous article. There were no differences in age, time since stroke, or baseline
primary outcome measures in those who underwent fMRI versus those who did not. The
study was approved by the institutional review boards of the UM Baltimore and Baltimore
Veterans Affairs Medical Center, and participants provided informed consent. Participants
were recruited for screening between January 2002 and April 2006. After screening, 142
patients were enrolled and 111 randomized after B2 to receive BATRAC or DMTE.
Design
Functional measures were collected as follows: (1) at 2 baseline times (B1,2) separated by 6
weeks, (2) after 6 weeks of BATRAC or DMTE intervention, and (3) 4 months after the
intervention. Training started after B2. After training, participants were asked to use their
paretic arm in daily life but not in new UE training regimens. fMRI data were collected at
B2 and after training.
Primary End Points of UE Assessment
1. Motor impairment was assessed through the Fugl-Meyer (FM) UE test, which is a
reliable and valid test of single joint movements, tasks, and reflexes.31–33
2. Motor function was measured as the time (WT) required to perform 15 tasks of a
reliable and valid modified version of the Wolf Motor Function Test (WMFT).34–36
Secondary End Points of UE Assessment
1. Components of the WMFT, including maximum weight carried (“Wolf weight”),
grip strength (“Wolf grip”), and a qualitative assessment of UE performance
(“Wolf function”), were determined. The WMFT was administered 3 times at B1 to
establish performance stability. The result of the second test was used to measure
performance at B1; an analysis showed that performance had stabilized by the
second administration.34
2. The Stroke Impact Scale, a reliable and valid questionnaire for this population, was
administered.37,38
3. Isokinetic strength of elbow flexion/extension movements of both arms were
measured on a Kincom Dynamometer (Chattanooga, TN).
4. Isometric strength of both arms were measured with the Chatillon force
dynamometer (The Scale People, Maryland) and a baseline hydraulic hand
dynamometer (Kom Kare, New York).
5. Range of motion measures included shoulder flexion/extension/abduction, elbow
flexion/extension, wrist flexion/extension, and thumb opposition, but no mean
changes exceeded the recognized 5 measurement error,39 and these data are
omitted.
6. Two verbal assessments of the participant’s perceptions after training were
assessed using a 5-point Likert scale where “3” indicates neither satisfied nor
dissatisfied with the training and neither improved nor declined after training,
respectively. For both questions, a higher score is favorable.
Functional Magnetic Resonance Imaging
fMRI was performed using a 1.5 T scanner (Philips, Eindhoven, The Netherlands) at the
Kirby Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore.30 Briefly,
60 coronal blood oxygenation-level-dependent weighted scans (echo planar imaging
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sequence, TE = 40 ms, TR = 3 s, 35–39 slices, slice thickness 5 mm) covering the entire
brain were acquired from the nonparetic and then the paretic arm. For each arm, scans were
obtained during 3 cycles of rest (10 images) followed by arm movement (10 images)
performed in response to an auditory cue given via headsets once every 3 s. During imaging,
the arm was strapped to a device that allowed elbow flexion/extension in one plane within a
defined range of motion from 45° relative to the standard anatomical position to 60° to 75°,
depending on the participant’s paretic arm movement ability. Each participant’s range of
motion was also applied to the nonparetic arm and subsequently kept constant. Compliance
with the protocol and the presence or absence of mirror movements and head motion was
assessed through a video monitor using 2 cameras (head and arms). A T1-weighted image
set (3D-MPRAGE, resolution 1 × 1 × 1 mm3) was acquired for anatomical localization. Data
were processed using SPM5 software (www.fil.ion.ucl.ac.uk/spm/software/spm5). Standard
protocols, including correction for slice timing differences, head motion (<3 mm in any
coordinate), and normalization to the MNI coordinate space, were used. Talairach space
registration was evaluated individually; the skull was removed and all cortical lesions were
masked to avoid image distortion. If not satisfactory, the registration process was repeated
without skull removal or with a modified lesion mask, resulting in successful registration for
all participants. All image data from participants with left-sided lesions were flipped about
the midsagittal plane, so the affected hemisphere was always on the right.
First-level statistical parametric maps were computed, including both the pretraining and the
posttraining scans of a given participant. A contrast post–pre was used to identify those
voxels whose activation increased between time points. Brain activation was measured by
computing the first eigenvariate for each series (ie, the scan for each time point) and for each
of 2 prespecified (primary) regions of interest (ROIs) and 6 additional exploratory ROIs and
time point. All ROIs were selected from the Automated Anatomical Labeling (AAL) atlas40
(for a detailed visualization refer to http://www.cyceron.fr/web/
aal__anatomical_automatic_labeling.html). Primary ROIs were prespecified in the study
protocol and were selected based on a priori knowledge of brain activation changes during
BATRAC.24 Precentral gyrus and superior frontal gyrus were primary ROIs (Figure 2).
Secondary ROIs had not been prespecified and were selected based on a review of single-
participant maps. Secondary ROIs included postcentral gyrus, cerebellar hemispheres
(anterior and posterior lobes), supramarginal gyrus, anterior cingulate cortex (ACC), and
SMA.
Randomization and Blinding
Participants were randomized after B2 to receive either BATRAC or DMTE using a
stratified block allocation scheme based on initial function (NIH Stroke Scale with 2 as
cutoff) and motor dominance of stroke. Because eligibility for fMRI analysis was not a
stratification factor, the 2 groups were slightly unbalanced. Testing was conducted in a
separate location from the training site by trained testers blinded to group assignment.
Training
Training occurred 3 times per week for 6 weeks, typical of an outpatient clinic, for a total of
18 sessions for each participant. There was a 9-week limit for completing the 18 sessions.30
For BATRAC, participants were seated at the training apparatus that consisted of T-bar
handles attached to nearly frictionless linear tracks. They completed 5 minutes of training
with the arms moving simultaneously (in phase) away and then toward the body in time to a
metronome set at their preferred speed, followed by 10 minutes of rest. Training continued
for 5 minutes with the arms moving alternately (antiphase) again with auditory cuing at a
preferred speed, followed by 10 minutes of rest. In-phase and antiphase training blocks were
repeated once each, achieving a total of 20 minutes of active continuous bilateral arm
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training in 1 hour for each participant. Frequency was held constant after the third session to
allow for initial task adaptation. Participants who were unable to grasp the handles
independently had their hands strapped to the T-bar. If necessary, antigravity arm support
was provided to avoid an improper arm position during the training; however, the
participants were encouraged to produce the forward and backward motions actively and to
reach further with their paretic arm throughout the training period by increasing the distance
to the target stop. Neither frequency nor resistance was progressed.
DMTE involved a customized set of 4 exercises based on neurodevelopmental principles,
including thoracic spine mobilization with weight shifting, scapular mobilization, weight
bearing with the paretic arm (elbow fixed), and opening the hand with finger extension. This
treatment emphasizes handling techniques that facilitate body and limbs to assume “normal”
positions. Participants were encouraged to actively move during the handling. DMTE was
performed using the same time schedule as BATRAC (4 cycles of active continuous 5-
minute training followed by 10 minutes of rest). Participants of both groups had equal, one-
on-one contact with trainers and equal time training, but the number of movements per
participant varied according to ability; 5 minutes of active continuous training was sufficient
before a rest. A treatment fidelity study, conducted by personnel not affiliated with the
study, confirmed study protocols.41
Statistical Analysis
There were separate data analyses for baseline, intervention, and retention phases. An
intention-to-treat-analysis included all participants at each time regardless of study
completion. Stability of measures from B1 to B2 was modeled in random-effects analysis of
variance (ANOVA) (SAS proc mixed, random intercept). The changes in outcome measures
during BATRAC versus DMTE were compared using ANOVA adjusted for age, sex, log
years since index stroke, the presence or absence of a motor dominant stroke, and the
preintervention B2 value of the outcome. A similar model compared changes in outcome
measures between groups during retention. A Wilcoxon ranked sums test analyzed the
Likert scale data. All analyses were 2 tailed with significance set at P < .05.
Whether BATRAC and DMTE differently affected brain activation during paretic or
nonparetic limb movement was analyzed using separate models for each ROI and each brain
side (contralesional and ipsilesional). Dependent variables were the difference in the ROIs
eigenvariates after therapy minus before. Independent variables included group (BATRAC
vs DMTE) and baseline brain activation (eigenvariate) for the respective ROI. Within-group
correlations between change in WT and change in ROI activation were assessed using
Pearson’s correlation coefficients. Corrections for multiple comparisons were applied for
prespecified (4) as well as the secondary (12) ROIs.
Results
A total of 119 subjects were studied during the baseline (8 dropped out between B2 and
randomization). Table 1 shows the physical characteristics of the 92 who completed either
BATRAC or DMTE. There were no significant differences between study groups with
respect to age, gender, time since stroke, side, or dominance of stroke or baseline functional
scores.
End Point Analysis
Preintervention—The 2 primary end points, FM and WT, did not change during the 6-
week baseline period. There were no differences in the secondary end point variables except
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for a decline of 0.18 on the 5-point scale (P < .02) for the Wolf function and 0.12 kg (P < .
02) for paretic arm elbow flexion isometric strength.
Intervention—Data (average of B1 and B2 to postintervention) are presented in Table 2
and include primary end points followed by secondary end points. Both interventions
improved FM scores, but there was no between-group difference. The FM change ranged
from +8 to −5 in BATRAC and +11 to −3 in DMTE. A significant decrease in average WT
within the groups also found no significant between-group difference. The WT change
ranged from −23.1 to 4.6 in BATRAC and −14.3 to 9.7 in DMTE. There was a significant
increase in ability to lift a weight following BATRAC but not DMTE (Wolf weight) and no
between-group difference. The model was significant (r2 = 0.22), indicating that being
female and having a more recent stroke predicted an improvement in this variable. There
was a significant within-group improvement in movement quality (Wolf function) following
each intervention but no between-group difference.
Following BATRAC, the subsections of Hand and Strength of the Stroke Impact Scale (SIS)
improved significantly, but there were no between-group differences. The model for
Strength was significant (r2 = 0.27), indicating that a lower initial score for this subsection is
a predictor of an improved score after intervention. Following DMTE, the total score and the
subsections Hand and Emotion demonstrated significant improvements. The model for
Emotion was significant (r2 = 0.30), indicating that a lower initial score for this subsection is
a predictor of an improved score after intervention.
There was an increase in isokinetic strength in elbow extension for both arms following
BATRAC but not DMTE. BATRAC significantly improved isometric strength in nonparetic
arm shoulder extension, wrist extension, and wrist flexion and in paretic arm shoulder
extension, whereas DMTE improved strength in paretic arm shoulder and wrist extension
and elbow flexion. There was a greater improvement in nonparetic elbow flexion and wrist
flexion isometric strength after BATRAC and in paretic wrist extension isometric strength
after DMTE.
On the Likert scale questionnaire, satisfaction with BATRAC was significantly higher than
with DMTE immediately after training (4.4 vs 3.8; P = .003) and remained slightly higher
after the retention period (4.1 vs 3.8; P = NS). Both groups reported comparable perceived
improvements immediately after training (BATRAC 4.0 vs DMTE 3.7) and after retention
(4.1 vs 3.9).
Retention—During 4-month retention, there were comparable declines in FM scores by
1.1 (P < .04; n = 39) in BATRAC and 1.0 (P < .05; n = 39) in DMTE. The WT and
secondary variables that improved after intervention were maintained during retention.
However, the SIS total score response during retention differed between groups, improving
by 10 after BATRAC and declining by 16 after DMTE (P < .05).
fMRI analysis—In the subset of 17 BATRAC and 21 DMTE patients who underwent
fMRI scanning, brain activation during paretic limb movement was differentially affected by
the 2 therapies. Among the prespecified ROIs, BATRAC led to a significantly greater
increase of activation in the ipsilesional precentral gyrus (contralateral to the moving, paretic
limb; between-group P = .011) and contralesional superior frontal gyrus (P = .012; Table 3);
see Figure 2. These probabilities remain significant if corrected for 4 comparisons (2 ROIs
on each side) using Bonferroni’s correction. A statistical “trend” (.05 < P < .1) was noted for
the ipsilesional superior frontal gyrus. Secondary ROIs that increased more after BATRAC
than DMTE included ipsilesional SMA, ACC, and postcentral gyrus (Table 3). None of
these between-group tests remained significant after correcting for 12 comparisons (6 ROIs
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on each side). All other regions except the posterior lobe of the cerebellum increased more
after BATRAC than DMTE, but no between-group differences were significant.
The activation increase in the contralesional superior frontal gyrus predicted 38% of the
improvement in WT outcomes after BATRAC (P = .010; if corrected for n = 4 comparisons,
2 primary ROIs on each side, P = .040; Figure 3). Secondary ROIs whose increase in
activation correlated with the improvement in WT included the bilateral ACC and
supramarginal gyrus. These correlations except one for the ipsilesional supramarginal gyrus
remained significant after correcting for 12 comparisons (6 secondary ROIs on each side).
The improvement in WT after DMTE was predicted by increased activation in the
ipsilesional superior frontal gyrus, contralesional supramarginal gyrus, and bilateral
postcentral gyrus; however, none of these correlations remained significant after multiple
comparison correction. No area of decreased activation was found after either BATRAC or
DMTE. There were no within- or between-group treatment differences in the activation
changes for either ROI or side during nonparetic limb movement.
Discussion
This randomized controlled trial demonstrates that (1) BATRAC is not superior to DMTE,
but both improve paretic arm function in stroke survivors, and the improvements are largely
maintained for 4 months; (2) BATRAC may operate through activation of primary and
secondary motor cortices, whereas DMTE may use additional mechanisms; (3) BATRAC
provides higher patient satisfaction than DMTE; and (4) no covariates consistently predicted
outcome across variables. Our finding of comparable functional improvements, despite brain
activation following BATRAC, disproves our hypothesis.
The improvement found in motor function after 6 weeks of BATRAC is consistent with
what was found in previous studies28–30,42; however, DMTE produced better results than
expected. Repetition or deliberate practice are major contributors to motor recovery,43,44
and both BATRAC and DMTE involve multiple active repetitions of specific movements. In
our effort to control for the repetition built into BATRAC, and matching dose by time, the
control group received a viable treatment program. Unlike the EXCITE trial that used a
usual care control group,6 other randomized trials of UE rehabilitation that use active dose-
matched training as controls also fail to show differences in outcomes between
treatments.13,45,46 The within-group gains seen after 6 weeks of either training program
were not observed in the 6 weeks between the 2 baseline assessments. Several other trials of
UE rehabilitation also demonstrate this point using delayed entry controls6 or attention
controls receiving lower-extremity47 or nonmovement exercises.12 Although the latter
control nicely for general physiological effects of exercise or confounds of repeated
assessments, they do not constitute an active alternative training control targeting the limb of
interest comparable to DMTE. Our results indicate, for primary outcomes, that repetition
may be more important than features that distinguish the 2 training approaches, such as
bilaterality and rhythmic cueing.
There are discrete differences between BATRAC and DMTE in the pattern of improvement
across secondary outcome measures. BATRAC, which requires active shoulder and elbow
movements of both arms, results in specific active strength gains for these 2 joints across
both arms, whereas DMTE, which focuses on static paretic shoulder, elbow, and wrist
extension, improves these joint actions. This differential result reflects a prior finding that
BATRAC improves temporal and spatial aspects of bilateral reaching, whereas DMTE only
improves a temporal aspect of unilateral reaching.48 It may be beneficial to combine
selected components of BATRAC and DMTE in sequence or parallel in future studies.
BATRAC requires less interaction between trainer and participant, whereas DMTE requires
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physical support and assistance to facilitate progress. BATRAC might be relatively easier to
translate into self-directed training in the clinic or home. The greater sense of satisfaction
and positive trend in total SIS scores during retention in the BATRAC group occurred
despite the closer trainer–participant relationship with DMTE and could have implications
for compliance in community trials.
Although our results suggest that both BATRAC and DMTE are viable as treatment options
for stroke survivors with chronic UE deficits, the degree of improvement in the primary end
points does not qualify as a clinically significant change according to Van der Lee et al,13
who suggest 10% improvement on an absolute scale. Inspection of the data reveals that both
groups had nonresponders, defined by those who maintained or decreased their scores on
variables. The treatment effect for our primary variables ranges from 11 to −5 on the FM
and an improved timing of −23.1 to 9.7 s for the WT, illustrating a wide range of response.
One explanation of the small treatment effects might be low training intensity. Both groups
received training for a total of 360 minutes, which is less than other targeted UE
interventions in chronic stroke. BATRAC intensity was not progressed in speed or
movement resistance. A second explanation might be that the severity deficit range enrolled
in this trial was large. Although severity level was not a significant predictor for most
variables in this trial, participants at both ends of the spectrum might benefit from a more
intensive training regimen to overcome floor or ceiling effects. In currently running studies,
we are exploring a more targeted population range and a more intense, progressive form of
BATRAC, as well as combining BATRAC with other complementary treatments. Despite
the smaller-than-anticipated motor function changes and the lack of superiority of
BATRAC, this trial has demonstrated differences between the treatments at the underlying
neural mechanism level.
The different brain activation responses suggest that BATRAC and DMTE may produce
their improvements through different mechanisms. We previously showed that participants
who improve arm function after BATRAC show bihemispheric, mainly contralesional,
activation of the premotor cortex by fMRI, whereas those who do not improve lack this
activation.30 The present data confirm this finding, showing that activation increases in the
contralesional superior frontal gyrus after BATRAC but not DMTE and that this increase is
associated with improved arm function. The superior frontal gyrus ROI is the same region
identified in our previous analysis as well as by other investigators49–54 as a region modified
during recovery of UE function. In contrast to BATRAC, DMTE is associated with smaller
increments in brain activation; distributed among different brain regions (except in the
ipsilesional premotor cortex, where activation increase correlates with DMTE-related WT
improvement). Also, the DMTE-related changes in brain activation did not meet strict
statistical criteria applying to multiple comparisons. Therefore, despite similar
improvements in arm function, BATRAC and DMTE appear to operate through different
brain mechanisms, or DMTE makes more use of adaptations that are outside the brain or not
measured by fMRI. These differences may be a result of the different circuitry used in
bilateral and unilateral arm movements as described earlier.
Supramarginal gyrus and ACC are other brain regions where changes in brain activation
correlated with improved arm function after BATRAC. The supramarginal gyrus may be
involved in attention,55 handwriting movements (left hemisphere region in right-handed
participants),56 and spatial perception57 and is shown to change activation during recovery
of function.51,58 Activation changes in this region during BATRAC may be related to the
participant paying more attention while moving the paretic arm or reflect improvements in
spatial perception of the paretic arm after BATRAC therapy. Both mechanisms could
improve arm function on WMFT and FM tests. The ACC is involved, among other tasks, in
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error-based movement learning.59 Activation in this region after BATRAC may reflect
motor learning mechanisms that are recruited by the therapy.
Other neurorehabilitative therapies based on motor learning strategies are associated with
brain activation. Juenger et al60 showed that CIMT leads to increases and shifts of activation
in frontal and motor cortices, mainly in the lesioned and, to a lesser extent, in the
nonaffected hemisphere in chronic stroke survivors,61 which parallels alterations in brain
structure.54 A recent review concluded that no single pattern of CNS change is observed
during recovery; rather, the pattern of neuroplasticity seems to depend on the training
intervention and the patient’s deficits caused by the initial lesion.62 Our findings support a
differential activation change resulting from the training program.
Conclusion
We found that 6 weeks of BATRAC or DMTE improves global arm impairment and
function comparably in chronic stroke survivors. Each treatment produced common and
different improvements in UE function that were sustained for at least 4 months. The
improvements after BATRAC appear to be mediated, at least in part, by cortical remodeling
centered in the ipsilesional precentral gyrus and the contralesional superior frontal gyrus
(premotor cortex), whereas DMTE seems to affect other neuroplastic processes. A
BATRAC intervention of increased intensity and duration, coupled with DMTE and other
UE interventions, may be necessary to capitalize on this neuroplasticity to maximize
improvements in UE function.
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Figure 1.
Study flow
Abbreviations: BATRAC, bilateral arm training with rhythmic auditory cueing; DMTE,
dose-matched therapeutic exercise.
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Figure 2.
Two primary regions of interest (ROIs), precentral gyrus (blue) and superior frontal gyrus
(green), are presented superimposed onto a T1-weighted scan of an exemplary participant.
These ROIs were prespecified based on prior studies and defined using the Automated
Anatomical Labeling atlas
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Figure 3.
The increase in activation in the contralesional superior frontal gyrus (ipsilateral to the
moving paretic limb) correlated with faster performance in the WMFT (time posttraining −
time pretraining) in BATRAC-trained participants (r = −0.62; P = .010). No such correlation
was found in the DMTE group
Abbreviations: WMFT, Wolf Motor Function Test; BATRAC, bilateral arm training with
rhythmic auditory cueing; DMTE, dose-matched therapeutic exercise.
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